Our results indicate that CENPE was significantly downregulated in both ovarian cancer cell lines at both the mRNA and protein levels following BAY-850 treatment (Fig. 5H, I, Supplementary Fig. 3). The gene discussed is CENPE; the disease is ovarian carcinoma.